Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin versus colistin plus meropenem for extensively drug-resistant Gram-negative infections
MOH_2017-10-03_000685Phase 3Not yet recruiting
- Sponsor
- פרופ יהודה כרמלי
- Start
- Jul 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Gram-negative bacterial infection, pneumonia and sepsis comparing Colistin + placebo with Colistin + meropenem (2 arms). Planned start Jul 2017; status: not yet recruiting.
02
Drugs
colistinmeropenem
03
Conditions
Gram-negative bacterial infectionpneumoniasepsis
Beyond the preview
Go deeper on MOH_2017-10-03_000685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-10-03_000685.